Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
achondroplasia, adequacy, Affordable, ahead, allegedly, alpha, andother, antibody, Appendix, apportioned, Arida, assert, assertion, banker, biosimilar, BLA, BPCA, bulk, cardiac, chaperone, China, climb, codified, Connecticut, construction, contemplated, creation, crystalline, CTA, degrading, dictated, distance, DNA, donut, Dublin, eleven, encouraged, explore, factor, fall, family, FCPA, fell, finite, formulary, fusion, GAA, gap, George, glycogen, harbor, holdback, hole, Hong, imposition, imprisonment, improper, infusion, interchangeability, interchangeable, Ireland, keratin, kilogram, Kong, leave, liter, lived, MHRA, milligram, mobility, modification, monetary, MRHA, narrowly, necessity, Nevada, older, Omitted, pathway, payor, peptide, pharmacodynamic, pharmacokinetic, pivotal, PPACA, preceding, precisely, Preliminary, purpose, purview, qualification, recurrent, reenter, reform, repair, resolution, retention, ribose, Sanofi, scrutiny, Shanghai, shortly, solid, stair, sulfate, sweeping, switching, Taiwan, teaching, unexpired, unfavorable, unidentified, variation, ventilation, view, vital, Western, zystor
Removed:
actively, adjunct, antidilutive, arose, assumption, bank, barred, Biomedical, capability, capitalization, commercialized, deficit, depreciated, dilutive, DTC, faculty, headcount, judicial, lab, label, list, Listing, medically, middle, North, ODT, originated, outflow, Overview, partner, percent, President, principally, reauthorized, reclassification, recordkeeping, refusal, responsive, resubmission, reverse, sampling, serviced, shorter, Stuart, sublicense, Swiedler, taxation, uninvested, unnecessary, Vice, vote, warning, warrant
Filing tables
Filing exhibits
- 10-K Annual report
- 21.1 Subsidiaries of Biomarin Pharmaceutical Inc.
- 23.1 Consent of KPMG LLP
- 23.2 Consent of Pricewaterhousecoopers, LLP
- 31.1 Certification of Chief Executive Officer Pusuant to Rules 13A-14(A)/15D-14(A)
- 31.2 Certification of Chief Financial Officer Pusuant to Rules 13A-14(A)/15D-14(A)
- 32.1 Certification of Chief Executive Officer and Chief Financial Officer
- 99.1 Biomarin/genzyme LLC Consolidated Financial Statements
Related press release
BMRN similar filings
Filing view
External links